Cargando…
A diverse collection of B cells responded to HIV infection in infant BG505
Increasing evidence suggests infants develop unique neutralizing antibody (nAb) responses to HIV compared to adults. Here, we dissected the nAb response of an infant whose virus is in clinical trials as a vaccine immunogen, with a goal of characterizing the broad responses in the infant to this anti...
Autores principales: | Simonich, Cassandra, Shipley, Mackenzie M., Doepker, Laura, Gobillot, Theodore, Garrett, Meghan, Cale, Evan M., Hennessy, Brianna, Itell, Hannah, Chohan, Vrasha, Doria-Rose, Nicole, Nduati, Ruth, Overbaugh, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233660/ https://www.ncbi.nlm.nih.gov/pubmed/34195680 http://dx.doi.org/10.1016/j.xcrm.2021.100314 |
Ejemplares similares
-
Early development of broad neutralizing antibodies in HIV-1 infected infants
por: Goo, Leslie, et al.
Publicado: (2014) -
Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
por: Yaffe, Zak A., et al.
Publicado: (2023) -
Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk
por: Milligan, Caitlin, et al.
Publicado: (2016) -
Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers
por: Carnathan, Diane G., et al.
Publicado: (2020) -
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
por: Whitaker, Neal, et al.
Publicado: (2019)